TI
Telemetry Investments Portfolio holdings
AUM
$42.8M
This Quarter Return
+6.29%
1 Year Return
-0.14%
3 Year Return
+72.15%
5 Year Return
+118.26%
10 Year Return
–
AUM
$49.9M
AUM Growth
+$49.9M
(-33%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-50.47%
Top 10 Holdings %
Top 10 Hldgs %
45.05%
Holding
153
New
30
Increased
18
Reduced
19
Closed
47
Top Buys
| 1 |
ELLI
Ellie Mae Inc
ELLI
|
$1.64M |
| 2 |
IDTI
Integrated Device Technology I
IDTI
|
$1.3M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
$790K |
| 4 |
Matinas BioPharma
MTNB
|
$708K |
| 5 |
Boeing
BA
|
$687K |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$4.17M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$2.77M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$2.68M |
| 4 |
Goldman Sachs
GS
|
$1.75M |
| 5 |
SCG
Scana
SCG
|
$1.68M |
Sector Composition
| 1 | Healthcare | 39.66% |
| 2 | Communication Services | 7.72% |
| 3 | Technology | 5.93% |
| 4 | Materials | 2.98% |
| 5 | Industrials | 2.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
1
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.12M | 2.6% | 1,940,157 -1,014,321 | -34% | -$2.68M |
|
|
IDTI
2
DELISTED
Integrated Device Technology I
IDTI
| $2.41M | 1.22% | 49,133 +26,500 | +117% | +$1.3M |
|
3
Xtant Medical Holdings
XTNT
$83.3M
| $2.35M | 1.19% | 768,913 -27,913 | -4% | -$85.1K |
|
|
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.99M | 1.01% | 142,140 -10,266 | -7% | -$144K |
|
|
ELLI
5
DELISTED
Ellie Mae Inc
ELLI
| $1.64M | 0.83% | +16,628 | New | +$1.64M |
|
|
AFMD
6
DELISTED
Affimed
AFMD
| $1.49M | 0.76% | 355,000 -70,398 | -17% | -$296K |
|
|
TRCO
7
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $1.32M | 0.67% | 28,557 +5,057 | +22% | +$233K |
|
|
RHT
8
DELISTED
Red Hat Inc
RHT
| $1.28M | 0.65% | 7,000 -7,195 | -51% | -$1.31M |
|
9
SPDR Gold Trust
GLD
$107B
| $1.22M | 0.62% | 10,000 -2,500 | -20% | -$305K |
|
|
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.16M | 0.59% | 242,826 +23,786 | +11% | +$113K |
|
11
Aclaris Therapeutics
ACRS
$209M
| $893K | 0.45% | 149,004 +50,504 | +51% | +$303K |
|
|
USG
12
DELISTED
Usg
USG
| $816K | 0.41% | 18,854 +10,000 | +113% | +$433K |
|
|
TCON
13
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $811K | 0.41% | 592,232 -374,743 | -39% | -$513K |
|
|
ARRS
14
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $790K | 0.4% | +25,000 | New | +$790K |
|
15
Rigel Pharmaceuticals
RIGL
$697M
| $771K | 0.39% | 300,000 +40,000 | +15% | +$103K |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $739K | 0.38% | 100,000 -75,000 | -43% | -$554K |
|
|
ROSE
17
DELISTED
Rosehill Resources Inc. Class A
ROSE
| $714K | 0.36% | 210,024 -39,009 | -16% | -$133K |
|
|
18
Matinas BioPharma
MTNB
$10.1M
| $708K | 0.36% | +650,000 | New | +$708K |
|
|
19
Boeing
BA
$177B
| $687K | 0.35% | +1,800 | New | +$687K |
|
|
S
20
DELISTED
Sprint Corporation
S
| $655K | 0.33% | 115,997 +54,600 | +89% | +$308K |
|
|
STML
21
DELISTED
Stemline Therapeutics, Inc.
STML
| $642K | 0.33% | 50,000 +8,412 | +20% | +$108K |
|
|
SBBP
22
DELISTED
Strongbridge Biopharma plc.
SBBP
| $620K | 0.31% | +124,544 | New | +$620K |
|
23
Corvus Pharmaceuticals
CRVS
$428M
| $604K | 0.31% | 150,199 +15,076 | +11% | +$60.6K |
|
24
Globalstar
GSAT
$3.79B
| $603K | 0.31% | 1,401,508 +479,987 | +52% | +$207K |
|
|
MXWL
25
DELISTED
Maxwell Technologies Inc
MXWL
| $598K | 0.3% | +133,802 | New | +$598K |
|